Corporate
Sarepta's ELEVIDYS Shows 70%+ Disease Slowing at 3 Years—Stock Surges 13% on Redemption Data
Jan 26
You're signed outSign in or to get full access.
Leadership at Sarepta Therapeutics
Browse executives, board members, and key leadership.
Executives at Sarepta Therapeutics
Douglas Ingram
Chief Executive Officer
CEO
Executive
Board
Cristin Rothfuss
Executive Vice President, Chief General Counsel and Corporate Secretary
Executive
Ian Estepan
President and Chief Operating Officer
Executive
Louise Rodino-Klapac
President, Research & Development and Technical Operations
Executive
Patrick Moss
Chief Commercial Officer
Executive
Rachael Potter
Chief Scientific Officer
Executive
Ryan Wong
Executive Vice President, Chief Financial Officer
Executive